|
Market Closed -
Nasdaq
06:00:00 05/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 827.72 USD | -1.87% |
|
+4.22% | +7.24% |
| Market Cap | 82.65B 71.12B 66.92B 61.13B 114B 7,804B 115B 791B 307B 4,004B 310B 304B 12,898B | P/E 2026 * |
19.2x | P/E 2027 * | 16.4x |
|---|---|---|---|---|---|
| Enterprise Value | 75.78B 65.21B 61.36B 56.05B 105B 7,155B 105B 725B 281B 3,671B 285B 278B 11,827B | EV / Sales 2026 * |
4.48x | EV / Sales 2027 * | 3.91x |
| Free-Float |
71.06% | Yield 2026 * |
0.47% | Yield 2027 * | 0.54% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Xetra
| RGO | End-of-day quote | |
|
Tradegate
| RGO | Real-time | |
|
Boerse Muenchen
| RGO | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
London S.E.
| 0R2M | Delayed | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript : Regeneron Pharmaceuticals, Inc.
| 1 day | -1.87% | ||
| 1 week | +4.22% | ||
| Current month | +3.58% | ||
| 1 month | +8.82% | ||
| 3 months | +31.65% | ||
| 6 months | +5.11% | ||
| Current year | +7.24% |
| 1 week | 779.08 |  | 859.34 |
| 1 month | 762.78 | | 859.34 |
| Current year | 591.52 | | 859.34 |
| 1 year | 541 | | 859.34 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Michael Brown
BRD | Director/Board Member | 85 | 01/06/1991 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/9/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 2/9/26 | Exercice | Director | 1,200 | 0.0012% | ||
| 19/8/26 | Exercice | General Counsel | 33,583 | 0.0326% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.87% | +4.22% | +45.93% | -0.47% | 82.65B | |
| -0.57% | +1.27% | -17.24% | -34.99% | 60.24B | |
| -2.23% | +5.48% | +499.46% | +29.31% | 58.11B | |
| -2.03% | -2.62% | -7.46% | +27.87% | 49.68B | |
| -4.58% | -2.73% | +2.93% | +157.71% | 46.66B | |
| -1.64% | +1.07% | +57.80% | -17.34% | 32.63B | |
| -0.98% | +1.91% | +48.35% | +95.93% | 25.69B | |
| -0.19% | -4.74% | +2.30% | +196.81% | 22.73B | |
| -1.13% | -2.45% | +65.99% | +110.75% | 16.51B | |
| +1.94% | -9.84% | -19.78% | +771.20% | 14.92B | |
| Average | -1.20% | -0.83% | +67.83% | +133.68% | 40.98B | |
| Weighted average by Cap. | -1.54% | +0.49% | +86.67% | +68.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.92B 14.56B 13.7B 12.51B 23.41B 1,598B 23.47B 162B 62.82B 820B 63.54B 62.16B 2,641B | 18.42B 15.85B 14.91B 13.62B 25.48B 1,739B 25.55B 176B 68.37B 892B 69.16B 67.65B 2,874B |
| Net income | 4.77B 4.11B 3.86B 3.53B 6.6B 451B 6.62B 45.67B 17.72B 231B 17.92B 17.53B 745B | 5.45B 4.69B 4.41B 4.03B 7.53B 514B 7.55B 52.1B 20.22B 264B 20.45B 20B 850B |
| Net Debt | -6.87B -5.91B -5.56B -5.08B -9.5B -648B -9.53B -65.71B -25.5B -333B -25.79B -25.23B -1,072B | -10.55B -9.08B -8.54B -7.81B -14.6B -996B -14.64B -101B -39.18B -511B -39.63B -38.77B -1,647B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | USD 827.72 | -1.87% | 561,170 |
| 03/09/26 | USD 843.47 | -1.00% | 496,255 |
| 02/09/26 | USD 852.03 | +3.42% | 749,453 |
| 01/09/26 | USD 823.82 | +3.10% | 682,806 |
| 31/08/26 | USD 799.08 | +0.62% | 894,268 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
